CYP7A1 and hyperlipidemia: Our results showed that Dp3-Sam treatment increased the CYP7A1, CPT1, ACOX, and PPARα expression in the liver tissue of HFD rats, indicating that Dp3-Sam intervention inhibited lipid accumulation via acceleration of lipid oxidation in HFD-induced hyperlipidemia rats.